Di Fabio Roberto, Marcotulli Christian, Tessa Alessandra, Leonardi Luca, Storti Eugenia, Pierelli Francesco, Santorelli Filippo M, Casali Carlo
Department of Medico-Surgical Sciences and Biotechnologies, "Sapienza" University of Rome, Corso della Repubblica, 79, 04100, Latina, Italy,
J Neurol. 2014 Apr;261(4):747-51. doi: 10.1007/s00415-014-7247-5. Epub 2014 Feb 12.
Pathogenic mutations in CYP7B1 account for SPG5, an autosomal recessive hereditary spastic paraplegia characterized by a complex phenotype including visual problems and cerebellar dysfunction. Sensory ataxia is not usually regarded as a typical clinical feature of SPG5. The purpose of this study was to describe six patients showing features of sensory ataxia as the prominent and/or initial symptoms of SPG5. Six patients from three distinct pedigrees (three women, three men; age 49.5 ± 18.2 years), all presenting gait unsteadiness and frequent falls since childhood, underwent clinical and molecular investigations. All showed marked sensory ataxic gait with positive Romberg's sign, as well as severely impaired position and vibration sense. Comparatively minor signs of pyramidal involvement were also detected. In four of the patients, brain MRI showed white matter hyperintensities on T2-weighted images. An already reported homozygous c.889A>G (p.T297A) mutation in SPG5/CYP7B1 was found in five patients from two families, whereas the remaining case harbored the novel c.250_251delC/p.L84Ffs*6 and c.266A>C/p.Y89S variants. Marked and enduring sensory ataxia can be a pivotal sign in SPG5, and expands the phenotypic spectrum associated with mutations in CYP7B1.
CYP7B1基因的致病性突变导致SPG5,这是一种常染色体隐性遗传性痉挛性截瘫,其特征为包括视觉问题和小脑功能障碍在内的复杂表型。感觉性共济失调通常不被视为SPG5的典型临床特征。本研究的目的是描述6例以感觉性共济失调为SPG5突出和/或初始症状的患者。来自三个不同家系的6例患者(3名女性,3名男性;年龄49.5±18.2岁),自幼均出现步态不稳和频繁跌倒,接受了临床和分子检查。所有患者均表现出明显的感觉性共济失调步态,闭目难立征阳性,以及严重受损的位置觉和振动觉。还检测到相对较轻的锥体束受累体征。4例患者的脑部MRI在T2加权图像上显示白质高信号。在来自两个家系的5例患者中发现了已报道的SPG5/CYP7B1纯合子c.889A>G(p.T297A)突变,而其余病例携带新的c.250_251delC/p.L84Ffs*6和c.266A>C/p.Y89S变异。明显且持久的感觉性共济失调可能是SPG5的关键体征,并扩展了与CYP7B1突变相关的表型谱。